Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet
2011

Simvastatin Reduces Atherosclerosis in Mice

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): Song Guohua, Liu Jia, Zhao Zhenmei, Yu Yang, Tian Hua, Yao Shutong, Li Guoli, Qin Shucun

Primary Institution: Institute of Atherosclerosis, Taishan Medical University

Hypothesis

Simvastatin might promote the expression of several factors involved in reverse cholesterol transport.

Conclusion

Simvastatin effectively reduces atherosclerotic lesion formation in apoE-/- mice fed a high-fat diet.

Supporting Evidence

  • Simvastatin reduced atherosclerotic lesion formation by 35% in the aortic root and 47% in the aortic arch.
  • Plasma HDL-C and apoA-I levels were significantly increased by simvastatin treatment.
  • Simvastatin treatment elevated the expression of hepatic ABCB4 and ABCG5.

Takeaway

Simvastatin helps lower bad cholesterol and prevents heart disease by helping the body get rid of cholesterol.

Methodology

21 male apoE-/- mice were divided into two groups, one treated with simvastatin and the other with a vehicle, and fed a high-fat diet for 6 weeks.

Limitations

The study was conducted on a specific mouse model, which may not fully represent human responses.

Participant Demographics

Male apoE-/- mice, 5 weeks old.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-511X-10-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication